Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aptose Bioscns (NQ: APTO )

5.208 USD +0.088 (+1.72%)
Streaming Delayed Price Updated: 10:59 AM EDT, Apr 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aptose Bioscns

< Previous 1 2 3 4 5 6 7 8 9 Next >
2021 Advanced Planning and Scheduling (APS) Software Market Growth Technology Trends with 9% of CAGR by 2027 – GLOBAL SHOP SOLUTIONS, INFORM SOFTWARE, PLEX SYSTEMS, SIEMENS AG
Tags Technology Computers & Software Europe
From AB Newswire
Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
From GlobeNewswire News Releases
Thinking about buying stock in Dolphin Entertainment, Hall of Fame Resort & Entertainment, Aptose Biosciences, Cinedigm, or Brainstorm Cell Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for DLPN, HOFV, APTO, CIDM, and BCLI. 
From PR Newswire
Aptose Reports Results for the Fourth Quarter and Full Year 2020
From GlobeNewswire News Releases
Aptose Expands Senior Leadership Team
From GlobeNewswire News Releases
Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021
From GlobeNewswire News Releases
Aptose Presents Highlights from ASH and Corporate Update Event
From GlobeNewswire News Releases
Aptose to Hold Corporate Update Sunday, December 6th
From GlobeNewswire News Releases
Aptose Reports Results for the Third Quarter 2020
From GlobeNewswire News Releases
Aptose to Present CG-806 and APTO-253 Data at the 2020 ASH Annual Meeting
Abstracts Accepted for Presentation 
From GlobeNewswire News Releases
Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020
From GlobeNewswire News Releases
Aptose Initiates Dosing of CG-806 in Patients with Acute Myeloid Leukemia
Phase 1 a/b Study of CG-806 in AML Initiates with Starting Dose of 450mg 
From GlobeNewswire News Releases
Aptose to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
From GlobeNewswire News Releases
Aptose to Present at September Investor Conferences
From GlobeNewswire News Releases
Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth Conference
From GlobeNewswire News Releases
Aptose Reports Results for the Second Quarter 2020
From GlobeNewswire News Releases
Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020
From GlobeNewswire News Releases
Aptose Announces Pricing of Public Offering of Common Shares
From GlobeNewswire News Releases
Aptose Announces Proposed Public Offering of Common Shares
From GlobeNewswire News Releases
Thinking about trading options or stock in Aptose Biosciences, Novavax, Inovio Pharmaceuticals, Ford Motor, or Carnival Corp?
InvestorsObserver issues critical PriceWatch Alerts for APTO, NVAX, INO, F, and CCL. 
From PR Newswire
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia
From GlobeNewswire News Releases
Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology Association
From GlobeNewswire News Releases
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
From GlobeNewswire News Releases
Aptose to Present Early CG-806 Clinical Findings at the 25th Congress of the European Hematology Association
From GlobeNewswire News Releases
Aptose to Present at 2020 RBC Capital Markets Global Healthcare Virtual Conference
From GlobeNewswire News Releases
Aptose Biosciences Establishes New At-The-Market Facility
From GlobeNewswire News Releases
Aptose Reports Results for the First Quarter 2020
From GlobeNewswire News Releases
Could This Be The Medical Breakthrough For The Next Decade
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Could This Be the Medical Breakthrough for The Next Decade
FN Media Group Presents Financialmorningpost.com Market Commentary 
From PR Newswire
IIROC Trade Resumption - APS
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.